A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of treatment with CCX140-B on urinary
albumin excretion in subjects with type 2 diabetes mellitus and albuminuria, as well as to
study the safety and efficacy of the medication in this patient population.